Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers.

Data is taken at the market close – at 4.10pm AEDT.

Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade.


Scroll or swipe to reveal table. Click headings to sort.

It was a unique day for Mindax Ltd (ASX:MDX), which re-listed on the ASX after being in suspension for the better part of two years.

Shares in the company initially rose as high as 20c, which marked a gain of around 6,000 per cent from its last traded price.

The stock closed at 3.7c — a mere 1,137pc higher. Earlier this week, MDX’s Chinese-owned joint venture partner received Foreign Investment Review Board (FIRB) approval to invest in the company’s Mt Forrest iron project in WA’s Yilgarn province.


Scroll or swipe to reveal table. Click headings to sort.

ASX debutante Juno Minerals (ASX:JNO) led the laggards, after raising $3.9m at 25 cents per share to develop two iron ore projects in WA.

While Juno’s listing coincides with booming iron ore prices, the stock closed at 17c for a day one fall of 32 per cent.

In a down day for new listings, pathology company Australian Clinical Labs (ASX:ACL) also fell after it raised over $408 million in the biggest ASX IPO of 2021 to date. Stockhead’s Nick Sundich has more here.